NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,624,451 | +0.6% | 398,826 | -0.3% | 1.57% | -2.7% |
| Q2 2023 | $40,376,749 | +9.7% | 400,126 | 0.0% | 1.61% | +8.6% |
| Q1 2023 | $36,811,623 | +1.5% | 400,126 | +0.1% | 1.48% | +0.5% |
| Q4 2022 | $36,250,201 | +20.0% | 399,583 | +0.5% | 1.48% | +13.0% |
| Q3 2022 | $30,209,000 | -10.7% | 397,433 | -0.7% | 1.31% | -12.0% |
| Q2 2022 | $33,817,000 | -4.2% | 400,067 | -0.6% | 1.49% | +2.3% |
| Q1 2022 | $35,307,000 | +0.0% | 402,366 | -0.3% | 1.45% | -3.7% |
| Q4 2021 | $35,305,000 | +7.2% | 403,632 | +0.2% | 1.51% | -0.9% |
| Q3 2021 | $32,940,000 | -11.1% | 402,791 | -0.8% | 1.52% | -10.5% |
| Q2 2021 | $37,054,000 | +7.2% | 406,124 | +0.5% | 1.70% | +3.6% |
| Q1 2021 | $34,560,000 | -9.6% | 404,303 | -0.1% | 1.64% | -19.8% |
| Q4 2020 | $38,224,000 | +8.4% | 404,788 | -0.2% | 2.04% | -6.0% |
| Q3 2020 | $35,276,000 | +0.2% | 405,663 | +0.6% | 2.18% | +4.3% |
| Q2 2020 | $35,215,000 | +9.4% | 403,190 | -7.0% | 2.09% | +5.7% |
| Q1 2017 | $32,195,000 | +3.7% | 433,480 | +1.7% | 1.97% | +4.5% |
| Q4 2016 | $31,061,000 | -11.5% | 426,430 | +0.2% | 1.89% | -20.7% |
| Q2 2016 | $35,098,000 | +13.9% | 425,380 | -0.0% | 2.38% | +22.8% |
| Q1 2016 | $30,822,000 | -14.3% | 425,493 | +1.8% | 1.94% | -10.1% |
| Q4 2015 | $35,960,000 | -6.4% | 417,943 | -0.0% | 2.16% | -1.3% |
| Q3 2015 | $38,436,000 | -6.3% | 418,143 | +0.3% | 2.19% | -7.1% |
| Q2 2015 | $41,001,000 | -0.5% | 416,927 | -0.3% | 2.35% | -3.2% |
| Q1 2015 | $41,218,000 | +5.2% | 417,992 | -1.1% | 2.43% | +2.5% |
| Q4 2014 | $39,176,000 | -2.3% | 422,792 | -0.8% | 2.37% | +2.3% |
| Q3 2014 | $40,098,000 | +10.3% | 425,992 | -0.4% | 2.32% | +11.0% |
| Q1 2014 | $36,350,000 | +5.6% | 427,542 | -0.1% | 2.09% | +6.3% |
| Q4 2013 | $34,414,000 | +4.8% | 428,142 | +0.0% | 1.97% | -6.7% |
| Q3 2013 | $32,835,000 | +9.2% | 428,042 | +0.7% | 2.11% | +6.6% |
| Q2 2013 | $30,057,000 | – | 425,067 | – | 1.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |